Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PFIZER INC Regulatory Filings 2007

Sep 7, 2007

29831_rns_2007-09-07_9ee470ae-bc57-4a5f-856d-ca451fb22723.zip

Regulatory Filings

Open in viewer

Opens in your device viewer

CORRESP 1 filename1.htm Corresp

September 7, 2007

VIA EDGAR Transmission Tim Buchmiller, Esq. Senior Attorney Securities and Exchange Commission Division of Corporate Finance 100 F Street, N.E. Mail Stop 6010 Washington, DC 20549

Re: Pfizer Inc. Definitive Proxy Statement Filed March 15, 2007 File No. 001-03699

Dear Mr. Buchmiller:

You have requested responses to the Comment Letter you recently sent Pfizer Inc. by September 21, 2007. As I indicated on the phone yesterday, due to the timing of our regularly scheduled Compensation Committee Meeting, we will not be in a position to meet that deadline. We hereby respectfully request that the deadline be extended until October 16, 2007.

If you have any questions or comments regarding the foregoing, do not hesitate to contact me at 212-733-4802

Very truly yours,

/s/ Margaret M. Foran Margaret M. Foran